Atnaujinkite slapukų nuostatas

El. knyga: Recent Advances in Human Fungal Diseases: Progress and Prospects

Edited by , Edited by
  • Formatas: PDF+DRM
  • Išleidimo metai: 22-Nov-2024
  • Leidėjas: Springer Nature
  • Kalba: eng
  • ISBN-13: 9789819749096
  • Formatas: PDF+DRM
  • Išleidimo metai: 22-Nov-2024
  • Leidėjas: Springer Nature
  • Kalba: eng
  • ISBN-13: 9789819749096

DRM apribojimai

  • Kopijuoti:

    neleidžiama

  • Spausdinti:

    neleidžiama

  • El. knygos naudojimas:

    Skaitmeninių teisių valdymas (DRM)
    Leidykla pateikė šią knygą šifruota forma, o tai reiškia, kad norint ją atrakinti ir perskaityti reikia įdiegti nemokamą programinę įrangą. Norint skaityti šią el. knygą, turite susikurti Adobe ID . Daugiau informacijos  čia. El. knygą galima atsisiųsti į 6 įrenginius (vienas vartotojas su tuo pačiu Adobe ID).

    Reikalinga programinė įranga
    Norint skaityti šią el. knygą mobiliajame įrenginyje (telefone ar planšetiniame kompiuteryje), turite įdiegti šią nemokamą programėlę: PocketBook Reader (iOS / Android)

    Norint skaityti šią el. knygą asmeniniame arba „Mac“ kompiuteryje, Jums reikalinga  Adobe Digital Editions “ (tai nemokama programa, specialiai sukurta el. knygoms. Tai nėra tas pats, kas „Adobe Reader“, kurią tikriausiai jau turite savo kompiuteryje.)

    Negalite skaityti šios el. knygos naudodami „Amazon Kindle“.

The book explores Candida and candidiasis, and Aspergillus and aspergillosis, two significant fungal infectious diseases.

In the first section, various aspects of Candida infection are covered. The book delves into the epidemiology of Candida infections, highlighting their prevalence and distribution. It thoroughly discusses diagnostics and pathogenesis of candidiasis, providing valuable insights into the identification, and understanding of the disease. Additionally, the book addresses the growing concern of drug resistance and provides an overview of current therapeutics for candidiasis.

Chapters in the second section examine the epidemiology of Aspergillus infections, providing a comprehensive understanding of their occurrence and impact. It discusses the diagnostics and pathogenesis of aspergillosis, shedding light on the methods for accurate diagnosis and the mechanisms by which the infection develops. It explores the host-pathogen interaction and the role of biofilms in these infections. Furthermore, the book addresses the pressing issue of drug resistance in aspergillosis and presents an overview of therapeutic approaches available for managing the disease.

This book serves as a valuable resource for researchers, clinicians, and healthcare professionals seeking in-depth knowledge of these fungal infectious diseases.

Part I. Candida and candidiasis.- Chapter
1. Diagnosis of candida and
candidiasis: current methods and future challenges.
Chapter
2. Fungal
fighters: a comprehensive guide to antifungal therapies of the past, present
and future.
Chapter
3. Candidiasis treatment: an evolutionary journey from
past to present and a glimse into the future.
Chapter
4. MDR in candida: the
real storm.
Chapter
5. Surviving the storm: how candida species master
adaptation for pathogenesis.
Chapter
6. Molecular cues and mechanisms of
pathogenesis in candida.
Chapter
7. Factors affecting drug resistance and
virulence in fungal pathogen.
Chapter
8. Unravelling drug resistance in
candida species: genetic, biofilm, transcriptional and epigenetic
perspectives.
Chapter
9. Biofilm formation in candida species.
Chapter
10.
Candida auris biofilm: a medical ambrosia.
Chapter
11. Candida albicans
mixed species biofilms and associated antimicrobial resistance.
Chapter
12.
Decoding the complex terrain of candida tropicalis induced candidiasis:
insights into epidemology, infection mechanisms, theraputics and drug
resistance.
Chapter
13. Candiasis drug resistance and translational
research.- Part II. Aspergillus and aspergillosis.
Chapter
14. Therapeutic
strategies and challenges in the management of aspergillus infections.-
Chapter
15. Aspergillus therapeutics: future agents.
Chapter
16. Recent
advances in the management of aspergillosis.
Chapter
17. Drug resistance
patterns in opportunistic aspergilli: a molecular perspective.
Chapter
18. A
comprehensive and intricate dynamics of aspergillus: implications,
therapeutic challenges, and drug resistance.
Chapter
19. Understanding
molecular pathogenesis of aspergillus fumigatus.
Dr. Saif Hameed is currently an associate professor at Amity Institute of Biotechnology, Amity University Haryana (AUH), India. Dr. Hameed did his Bachelorss from University of Delhi and Masterss from Jamia Hamdard in 2003 and 2005 respectively. He did his doctoral studies in Life Sciences at Jawaharlal Nehru University in 2010 where he also received CSIR research associateship for the one-year postdoctoral work. He worked as visiting scholar at Institut für Mikrobiologie, Heinrich-Heine-Universität, Düsseldorf, Germany in 2008. He received the Young Scientist award under the fast-track Scheme from the science and engineering research board, Department of Science and Technology, New Delhi in the year 2012. He is a life member of the International Society of Infectious Diseases (ISID), Association for Microbiologists (AMI), India and Society of Biological Chemists (SBC), India. Dr. Hameed is actively engaged in research in the field of medical microbiology particularly antibiotic resistance in pathogenic fungi. He has 70 peer-reviewed papers to his credit in international journals of repute along with 6 books. He has supervised 6 PhD students and guided 25 UG and PG level students for their research projects.







Dr. Pooja Vijayaraghavan is a as professor at Amity University Uttar Pradesh, Noida, India. She is a prominent scientist in the field of antifungal research. Her major focus area is to evaluate the biological efficacy of naturally occurring small molecules and synthetically designed analogues against pathogenic fungal species, with a particular emphasis on human pathogens such as Aspergillus fumigatus and Rhizopus oryzae, along with plant pathogenic fungi like Magnaporthe oryzae and Curvularia lunata. She has published many peer-reviewed articles which have provided invaluable global perspectives and insights. Dr. Vijayaraghavan has obtained 17+ patents, with four patents already granted and others currently undergoing scrutiny. Her research has successfully transformed three patented innovations into practical products in collaboration with various industries. These include a herbal hand sanitizer, a biopolymer-based film for enhancing the shelf life of perishable fruits and vegetables, and a biopesticide to combat rice blast disease.